Watch RXST. Know when insiders buy.
One email the day a filing lands. Free.
Work order
41
WATCH · insiders 44, shorts 38
Insiders, 90 days
−$118K
net selling · 0 buys, 4 sells
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $265.2MP/E —DIV YIELD —FCF YIELD -10.24%REV TTM $127.6M −13.2%NET INCOME −$46.9MNET CASH $13.4M52W 4.59 – 13.09SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q2 2026 · Jun 30 | $33.7M | +0.3% | 76.7% | −$13.8M | −$12.1M | — | -0.29 | −$9.5M | $2M | −$11.5M | Aug 5 |
| Q1 2026 · Mar 31 | $30.9M | −18.5% | 76.1% | −$17.8M | −$15.9M | — | -0.38 | −$10.9M | $759K | −$11.7M | Aug 5 |
| Q4 2025 · Dec 31derived | $32.6M | −18.9% | 77.5% | −$11.3M | −$9.2M | — | -0.22 | −$1.1M | $1.1M | −$2.3M | Feb 25 |
| Q3 2025 · Sep 30 | $30.3M | −14.1% | 79.9% | −$12.2M | −$9.8M | — | -0.24 | −$1.2M | $581K | −$1.8M | Nov 5 |
| Q2 2025 · Jun 30 | $33.6M | −3.6% | 74.9% | −$14M | −$11.8M | — | -0.29 | −$4.4M | $1.5M | −$5.9M | Aug 5 |
| Q1 2025 · Mar 31 | $37.9M | +28.4% | 74.8% | −$10.7M | −$8.2M | — | -0.20 | −$8.8M | $575K | −$9.4M | Aug 5 |
| Q4 2024 · Dec 31derived | $40.2M | +40.7% | 71.6% | −$8.6M | −$5.9M | — | -0.15 | −$4.3M | $847K | −$5.1M | Feb 25 |
| Q3 2024 · Sep 30 | $35.3M | +59.1% | 71.4% | −$9.2M | −$6.3M | — | -0.16 | $650K | $1.1M | −$453K | Nov 5 |
| Q2 2024 · Jun 30 | $34.9M | — | 69.5% | −$8.3M | −$6.1M | — | -0.16 | −$4M | $1.5M | −$5.5M | Nov 5 |
| Q1 2024 · Mar 31 | $29.5M | — | 70.1% | −$10.7M | −$9.1M | — | -0.25 | −$9.3M | $2M | −$11.3M | Nov 5 |
| Q4 2023 · Dec 31derived | $28.6M | — | 61.8% | −$10.9M | −$9.2M | — | -0.25 | −$8.3M | $1.6M | −$9.9M | Feb 25 |
| Q3 2023 · Sep 30 | $22.2M | — | 61.9% | −$12.5M | −$12.4M | — | -0.35 | −$8M | $653K | −$8.6M | Nov 7 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2025 · to Dec 31 | $134.5M | 76.6% | −$48.2M | −$38.9M | -29.0% | -0.95 | −$15.5M | $3.8M | −$19.3M | — | — |
| FY2024 · to Dec 31 | $139.9M | 70.7% | −$36.9M | −$27.5M | -19.6% | -0.71 | −$16.9M | $5.4M | −$22.4M | — | — |
| FY2023 · to Dec 31 | $89.1M | 60.4% | −$50.1M | −$48.6M | -54.6% | -1.41 | −$41.6M | $4.8M | −$46.4M | — | — |
| FY2022 · to Dec 31 | $49M | 43.5% | −$63.3M | −$66.8M | -136.2% | -2.41 | −$58.9M | $2.4M | −$61.2M | — | — |
| FY2021 · to Dec 31 | $22.6M | 20.0% | −$52.8M | −$48.7M | -215.5% | -3.57 | −$44.7M | $1.9M | −$46.6M | — | — |
| FY2020 · to Dec 31 | $14.7M | 11.6% | −$35.4M | $27.6M | 187.9% | 0.15 | −$35.2M | $2.5M | −$37.7M | — | — |
Every number comes from RxSight, Inc.'s own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.